抑郁症患者脂质代谢紊乱的研究进展
Research Progress of Lipid Metabolism Disorder in Patients with Depression
DOI: 10.12677/ACM.2021.1111713, PDF,   
作者: 徐琪坤*:青海大学研究生院,青海 西宁;郝贵生#:青海省人民医院,青海 西宁
关键词: 抑郁症脂质代谢总胆固醇不饱和脂肪酸Depression Lipid Metabolism Total Cholesterol Omega-3 Polyunsaturated Fatty Acids
摘要: 目前抑郁症的发病机制尚不明确,大量研究提示脂质代谢异常与抑郁症的发病关系密切。本文系统综述抑郁症与脂质代谢的研究进展,为抑郁症的研究提供新的思路。
Abstract: At present, the pathogenesis of depression is not clear, a large number of studies suggest that abnormal lipid metabolism is closely related to the onset of depression. This paper systematically reviews the research progress of depression and lipid metabolism, and provides new ideas for the study of depression.
文章引用:徐琪坤, 郝贵生. 抑郁症患者脂质代谢紊乱的研究进展[J]. 临床医学进展, 2021, 11(11): 4861-4865. https://doi.org/10.12677/ACM.2021.1111713

参考文献

[1] Saher, G., Brugger, B., Lappe-Siefke, C., et al. (2005) High Cholesterol Level Is Essential for Myelin Membrane Growth. Nature Neuroscience, 8, 468-475. [Google Scholar] [CrossRef] [PubMed]
[2] Zhang, J. and Liu, Q. (2015) Cholesterol Metabolism and Homeostasis in the Brain. Protein Cell, 6, 254-264. [Google Scholar] [CrossRef] [PubMed]
[3] Nave, K.A. and Ehrenreich, H. (2014) Myelination and Oligodendrocyte Functions in Psychiatric Diseases. JAMA Psychiatry, 71, 582-584. [Google Scholar] [CrossRef] [PubMed]
[4] Ghosh, S., Dyer, R.A. and Beasley, C.L. (2017) Evidence for Altered Cell Membrane Lipid Composition in Postmortem Prefrontal White Matter in Bipolar Disorder and Schizophrenia. Journal of Psychiatric Research, 95, 135-142. [Google Scholar] [CrossRef] [PubMed]
[5] Rottstadt, F., Han, P., Weidner, K., et al. (2018) Reduced Olfactory Bulb Volume in Depression—A Structural Moderator Analysis. Human Brain Mapping, 39, 2573-2582. [Google Scholar] [CrossRef] [PubMed]
[6] He, Y., Wang, Y., Wu, Z., et al. (2020) Metabolomic Abnormalities of Purine and Lipids Implicated Olfactory Bulb Dysfunction of CUMS Depressive Rats. Metabolic Brain Disease, 35, 649-659. [Google Scholar] [CrossRef] [PubMed]
[7] Spalding, K.L., Bergmann, O., Alkass, K., et al. (2013) Dynamics of Hippocampal Neurogenesis in Adult Humans. Cell, 153, 1219-1227. [Google Scholar] [CrossRef] [PubMed]
[8] Videbech, P. and Ravnkilde, B. (2004) Hippocampal Volume and Depression: A Meta-Analysis of MRI Studies. American Journal of Psychiatry, 161, 1957-1966. [Google Scholar] [CrossRef] [PubMed]
[9] Dranovsky, A. and Hen, R. (2006) Hippocampal Neurogenesis: Regulation by Stress and Antidepressants. Biological Psychiatry, 59, 1136-1143. [Google Scholar] [CrossRef] [PubMed]
[10] Li, Q., Yang, D., Wang, J., et al. (2015) Reduced Amount of Olfactory Receptor Neurons in the Rat Model of Depression. Neuroscience Letters, 603, 48-54. [Google Scholar] [CrossRef] [PubMed]
[11] Lauritzen, I., Blondeau, N., Heurteaux, C., et al. (2000) Polyunsaturated Fatty Acids Are Potent Neuroprotectors. EMBO Journal, 19, 1784-1793. [Google Scholar] [CrossRef] [PubMed]
[12] Patel, A.J., Lazdunski, M. and Honore, E. (2001) Lipid and Mechano-Gated 2P Domain K(+) Channels. Current Opinion in Cell Biology, 13, 422-428. [Google Scholar] [CrossRef
[13] Venna, V.R., Deplanque, D., Allet, C., et al. (2009) PUFA Induce Antidepressant-Like Effects in Parallel to Structural and Molecular Changes in the Hippocampus. Psychoneuroendocrinology, 34, 199-211. [Google Scholar] [CrossRef] [PubMed]
[14] Schmidt, S., Willers, J., Stahl, F., et al. (2012) Regulation of Lipid Metabolism-Related Gene Expression in Whole Blood Cells of Normo- and Dyslipidemic Men after Fish Oil Supplementation. Lipids in Health and Disease, 11, 172. [Google Scholar] [CrossRef
[15] Sadeghi, M., Roohafza, H., Afshar, H., et al. (2011) Relationship between Depression and Apolipoproteins A and B: A Case-Control Study. Clinics (Sao Paulo), 66, 113-117. [Google Scholar] [CrossRef
[16] Appleton, K.M., Rogers, P.J. and Ness, A.R. (2010) Updated Systematic Review and Meta-Analysis of the Effects of n-3 Long-Chain Polyunsaturated Fatty Acids on Depressed Mood. The American Journal of Clinical Nutrition, 91, 757-770. [Google Scholar] [CrossRef] [PubMed]
[17] Su, K.P., Huang, S.Y., Chiu, C.C., et al. (2003) Omega-3 Fatty Acids in Major Depressive Disorder. A Preliminary Double-Blind, Placebo-Controlled Trial. European Neuropsychopharmacology, 13, 267-271.
[18] Bharti, V., Bhardwaj, A., Hood, K., et al. (2021) A Systematic Review and Meta-Analysis of Lipid Metabolomic Signatures of Major Depressive Disorder. Journal of Psychiatric Research, 139, 197-205. [Google Scholar] [CrossRef] [PubMed]
[19] Segoviano-Mendoza, M., Cardenas-De, L.C.M., Salas-Pacheco, J., et al. (2018) Hypocholesterolemia Is an Independent Risk Factor for Depression Disorder and Suicide Attempt in Northern Mexican Population. BMC Psychiatry, 18, 7. [Google Scholar] [CrossRef] [PubMed]
[20] Ekinci, O. and Ekinci, A. (2017) The Connections among Suicidal Behavior, Lipid Profile and Low-Grade Inflammation in Patients with Major Depressive Disorder: A Specific Relationship with the Neutrophil-to-Lymphocyte Ratio. Nord J Psychiatry, 71, 574-580. [Google Scholar] [CrossRef] [PubMed]
[21] Scharnholz, B., Gilles, M., Marzina, A., et al. (2014) Do Depressed Patients without Activation of the Hypothalamus-Pituitary-Adrenal (HPA) System Have Metabolic Disturbances? Psychoneuroendocrinology, 39, 104-110. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, S., Ding, Y., Wu, F., et al. (2016) Serum Lipid Levels and Suicidality: A Meta-Analysis of 65 Epidemiological Studies. Journal of Psychiatry & Neuroscience, 41, 56-69. [Google Scholar] [CrossRef] [PubMed]
[23] Scanlon, S.M., Williams, D.C. and Schloss, P. (2001) Membrane Cholesterol Modulates Serotonin Transporter Activity. Biochemistry, 40, 10507-10513. [Google Scholar] [CrossRef] [PubMed]
[24] Jow, G.M., Yang, T.T. and Chen, C.L. (2006) Leptin and Cholesterol Levels Are Low in Major Depressive Disorder, But High in Schizophrenia. Journal of Affective Disorders, 90, 21-27. [Google Scholar] [CrossRef] [PubMed]
[25] Wu, Y., Tang, J., Zhou, C., et al. (2016) Quantitative Proteomics Analysis of the Liver Reveals Immune Regulation and Lipid Metabolism Dysregulation in a Mouse Model of Depression. Behavioural Brain Research, 311, 330-339. [Google Scholar] [CrossRef] [PubMed]
[26] Levant, B., Ozias, M.K., Davis, P.F., et al. (2008) Decreased Brain Docosahexaenoic Acid Content Produces Neurobiological Effects Associated with Depression: Interactions with Reproductive Status in Female Rats. Psychoneuroendocrinology, 33, 1279-1292. [Google Scholar] [CrossRef] [PubMed]
[27] Kitajka, K., Puskas, L.G., Zvara, A., et al. (2002) The Role of n-3 Polyunsaturated Fatty Acids in Brain: Modulation of Rat Brain Gene Expression by Dietary n-3 Fatty Acids. Proceedings of the National Academy of Sciences of the United States of America, 99, 2619-2624. [Google Scholar] [CrossRef] [PubMed]
[28] Sonawalla, S.B., Papakostas, G.I., Petersen, T.J., et al. (2002) Elevated Cholesterol Levels Associated with Nonresponse to Fluoxetine Treatment in Major Depressive Disorder. Psychosomatics, 43, 310-316. [Google Scholar] [CrossRef] [PubMed]
[29] Mcnamara, R.K., Strimpfel, J., Jandacek, R., et al. (2014) Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder. Pharma Nutrition, 2, 38-46. [Google Scholar] [CrossRef] [PubMed]
[30] Zheng, P., Gao, H., Qi, Z., et al. (2013) Peripheral Metabolic Abnormalities of Lipids and Amino Acids Implicated in Increased Risk of Suicidal Behavior in Major Depressive Disorder. Metabolomics, 9, 688-696. [Google Scholar] [CrossRef
[31] Nemets, B., Stahl, Z. and Belmaker, R.H. (2002) Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder. American Journal of Psychiatry, 159, 477-479. [Google Scholar] [CrossRef] [PubMed]